Status: current, Defined. Date: 31-Jul 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2593631000168115 | Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2593641000168112 | Soflax (AN) tablet, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | Is a | docusate sodium 50 mg + sennoside B 8 mg tablet, 100 | true | Inferred relationship | Some | ||
| Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | has TPUU | Soflax (AN) tablet | true | Inferred relationship | Some | 1 | |
| Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | has TP | Soflax (AN) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Soflax (AN) tablet, 100, bottle | Is a | True | Soflax (AN) (docusate sodium 50 mg + sennoside B 8 mg) tablet, 100 tablets (trade product pack) | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product pack reference set
FHIR